PE/Cyanine5 Anti-Mouse CD28 Antibody[37.51]

PE/Cyanine5 Anti-Mouse CD28 Antibody[37.51]

Introducing the PE/CYANINE5 Anti-Mouse CD28 Antibody [37.51], a highly advanced and meticulously developed product designed to cater to the specific needs of scientific research and experimentation. This antibody, meticulously crafted using cutting-edge technology, offers unparalleled precision and accuracy in its performance.

The PE/CYANINE5 Anti-Mouse CD28 Antibody [37.51] is specifically engineered to target and bind with the CD28 protein found on the surface of mouse cells. This antibody's exceptional affinity and specificity ensure reliable and reproducible results, making it an indispensable tool for immunological studies and related applications.

With its vibrant PE/CYANINE5 conjugation, this antibody enables efficient and simultaneous multicolor flow cytometry analysis. Its exceptional brightness and minimal spectral overlap contribute to enhanced data resolution and clarity, facilitating the identification and characterization of CD28-expressing cells with utmost precision.

Furthermore, the PE/CYANINE5 Anti-Mouse CD28 Antibody [37.51] boasts exceptional stability and longevity, ensuring consistent performance over extended periods. Its robust formulation guarantees minimal background noise and non-specific binding, thereby minimizing experimental artifacts and maximizing data accuracy.

This product is meticulously manufactured under stringent quality control measures, adhering to the highest industry standards. Each batch undergoes rigorous testing to ensure optimal performance, reliability, and consistency, providing researchers with the utmost confidence in their experimental outcomes.

In summary, the PE/CYANINE5 Anti-Mouse CD28 Antibody [37.51] represents a pinnacle of scientific innovation, offering researchers an invaluable tool for their immunological investigations. Its exceptional specificity, brightness, stability, and reliability make it an indispensable asset in the pursuit of scientific knowledge and breakthrough discoveries.